ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    The Immunosuppressive Effects of Erythropoietin Do Not Confer Lower Rates of Acute Rejection in Post Kidney Transplant Recipients Receiving Darbepoetin

    B. Fischbach,1 S. Gonzalez,1 A. Yango,1 A. Chandrakantan,2 A. Rajagopal,2 K. Rice,2 L. Melton,2 Y. Barri,2 M. Saim,2 N. Onaca,1 R. Ruiz,1 M. Levy,1 G. Klintmalm.2

    1Simmons Transplant Institute, Baylor All Saints Medical Center, Fort Worth, TX; 2Simmons Transplant Institute, Baylor University Medical Center, Dallas, TX.

    Background: The correction of anemia has been associated with improved kidney allograft outcomes. Recently, erythropoietin was shown to directly suppress alloreactive human T-cells by inhibiting…
  • 2015 American Transplant Congress

    Longitudinal Trends in Wait Times and Use of Bridging Locoregional Therapies in Hepatocellular Carcinoma Patients undergoing Orthotopic Liver Transplantation: UNOS Population Study

    M. Xing, H. Kim.

    Interventional Radiology, Department of Radiology, University of Pittsburgh School of Medicine, Pittsburgh, PA.

    Background: Trends in bridging locoregional therapies (LRT) and wait times for patients with hepatocellular carcinoma (HCC) undergoing orthotopic liver transplantation (OLT) have not been investigated…
  • 2015 American Transplant Congress

    Controlled Hemodilution in Infant Liver Transplants: A Single Center Experience

    T. Todo,1 A. Gallo,1 J. Mendoza,2 T. Pham,1 C. Esquivel.1

    1Dept of Surgery, Stanford University, Palo Alto, CA; 2Dept of Anesthesia, Stanford University, Palo Alto, CA.

    Introduction: Hepatic artery thrombosis (HAT) remains a major comorbidity in pediatric liver transplants often resulting in graft loss and mortality. Controlled hemodilution decreases blood viscosity…
  • 2015 American Transplant Congress

    Preliminary Results of a Novel Induction Regimen Using Anti-Thymocyte Globulin (Rabbit) (rATG) Plus Basiliximab in a Pediatric Patient Population Undergoing Kidney Transplantation

    D. Halleran,1 S. Schurman, T. Welch, V. Whittaker.

    1Surgery, State University New York Upstate Medical University, Syracuse, NY; 2Pediatric Nephrology, State University New York Upstate Medical University, Syracuse, NY.

    Purpose: We report the outcomes from single center experience with the novel induction regimen using rATG (3 mg/kg) in divided doses given on operative day…
  • 2015 American Transplant Congress

    Outcome of Adult Kidney Transplant Candidates With Previous Malignancy: Analysis of 14-Year Waiting List Data in the United States

    A. Santos, M. Casey, S. Rehman, X. Wen, K. Andreoni, K. Womer.

    College of Medicine, Univ. of Florida, Gainesville, FL.

    Purpose: We aimed to study the difference in patient survival and transplantation probability rates of adult kidney transplant (KT) candidates with and without history of…
  • 2015 American Transplant Congress

    Development of a Post-Graduate Year 2 Solid Organ Transplant Pharmacy Residency Program at an Academic Medical Center

    A. Guyton, D. Clark, M. Todd, J. Peterson, A. James.

    Department of Pharmacy, University of Alabama at Birmingham Hospital, Birmingham, AL.

    The University of Alabama at Birmingham (UAB) Hospital performs a high volume of solid organ transplants each year, allowing for residents and students from many…
  • 2015 American Transplant Congress

    Cytomegalovirus and BK Infections in Sensitized Kidney Transplant Recipients

    S. Parajuli, B. Muth, J. Turk, M. Mohamed, D. Mandelbrot, A. Djamali.

    Department of Medicine, University of Wisconsin School of Medicine and Pubic Health, Madison.

    Background:There is little information on the incidence, risk factors and outcomes associated with cytomegalovirus (CMV) and BK infections in sensitized patientsMethods:We examined 254 kidney transplant…
  • 2015 American Transplant Congress

    Incidence of Hepatitis B Virus Reactivation in Kidney Transplant Patients Who Received Rituximab Administration

    K. Omoto, M. Okumi, D. Toki, T. Shimizu, H. Ishida, K. Tanabe.

    Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.

    OBJECTIVE:The efficacy of antiviral prophylaxis for rituximab (RIT)-associated hepatitis B virus (HBV) reactivation in patients with lymphoma has been recently reported. However, the immunological effect…
  • 2015 American Transplant Congress

    The Impact of Duration of Brain Death on Outcomes in Abdominal Organ Transplantation: Rush and Retrieve or Rather Relax and Repair?

    C. Boffa,1 E. Curnow,2 K. Martin,2 R. Johnson,2 R. Ploeg.1

    1Nuffield Department of Surgical Sciences, Oxford, United Kingdom; 2NHS Blood and Transplant, Bristol, United Kingdom.

    Background: Brain death (BD) induces a progressive systemic pro-inflammatory and coagulatory response affecting function of the grafts-to-be and survival. With longer BD duration more injury…
  • 2015 American Transplant Congress

    Immune Reconstitution in Recipients of Living Donor Kidney/Hematopoietic Stem + Facilitating Cell Transplants

    J. Leventhal,1 M. Elliott,2 E. Yolcu,2 L. Bozulic,3 D. Tollerud,3 J. Mathew,1 I. Konieczna,1 M. Ison,1 M. Badder,3 M. Abecassis,1 J. Miller,1 L. Gallon,1 S. Ildstad.3

    1Comprehensive Transplant Center, Northwestern Memorial Hospital, Chicago, IL; 2University of Louisville, Institute for Cellular Therapeutics, Louisville, KY; 3Regenerex, LLC, Louisville, KY.

    We report the long-term results from a reduced-intensity nonmyeloablative conditioning approach to establish high levels of donor chimerism without graft-versus-host disease (GVHD) in mismatched related…
  • « Previous Page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences